Therapeutic equivalence? [Design Issues]

posted by Dr_Dan  – Germany, 2011-02-08 15:40 (5606 d 01:21 ago) – Posting: # 6593
Views: 8,910

Dear d_labes
not all anti-cancer drugs are cytotoxic, for example aromatase inhibitors for treating breast cancer or imatinib, a phenylaminopyrimidine derivative, which is a selective inhibitor of the tyrosine kinase activity of BCR-ABL fusion gene (oncoprotein), the product of the Philadelphia chromosome. You can test these drugs in healthy subjects, no problem. Other drugs like capecitabine or temozolomide can only be tested in patients. So it depends.
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
125 visitors (0 registered, 125 guests [including 16 identified bots]).
Forum time: 18:01 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5